ConditionOsteoarthritis
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age19-80
SponsorNext Biomedical Co., Ltd.
About this trial
In patients with chronic elbow or wrist pain, the pain is controlled by conventional conservative therapy The pain reduction effect of Nexsphere-F embolization in patients who need additional treatment It is intended to demonstrate safety.
Eligibility criteria
Qualifiers
Those aged 19 to 80
Anyone who can provide a consent form
A person with a life expectancy of at least 12 months
Those who have not responded or failed in preservation treatment for at least three months(e.g. NSAIDS/physical therapy/steroidal joint injections, etc.)
Disqualifiers
Those with a VAS Score of less than 4 and Mild Elbow or Wrist Pain
Chronic Renal Insufficiency(Serum creatinine > 2mg/dL)
allergy to iodide contrast agents that do not respond to steroids
Those with acute infection or malignancy
Trial design
Treatments tested in this trial
- Transcatheter Arterial Micro-Embolization
Treatment groups
38 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov